MYC and neoplasm: As reviewed by Skaar et al. (5, 6), E3 SCF targets an array of oncogene products, such as β-catenin (by SCFβTrCP) and c-Myc (by SCFFbxw7), as well as tumor suppressors, such as p27 and p21 (by SCFSkp2).